Prev Arrow Stocks

Doximity, Inc. ($DOCS) Stock Forecast: Down 5.7% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Doximity, Inc.?

DOCS is a healthcare technology company specializing in electronic health records and telemedicine solutions. The overall market sentiment is bearish today.

Why is Doximity, Inc. going down?

DOCS stock is down 5.7% on Oct 10, 2025 14:25

  • The bearish movement in DOCS could be attributed to a broader negative sentiment in the healthcare sector, as evidenced by the downgrades in other healthcare companies like Allogene Therapeutics and Akero Therapeutics.
  • The change in analyst outlook for DOCS may have raised concerns among investors, leading to selling pressure on the stock.
  • It is possible that investors are reevaluating their positions in healthcare technology companies, leading to a shift away from previously bullish stocks like DOCS.

DOCS Price Chart

DOCS Technical Analysis

DOCS News

This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Allogene Therapeutics ( NASDAQ:ALLO ) , Akero Therapeutics ( NASDAQ:AKRO )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Andrew S.

https://www.benzinga.com/news/25/10/48147496/this-keysight-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday

0 News Article Image This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Allogene Therapeutics  ( NASDAQ:ALLO ) , Akero Therapeutics  ( NASDAQ:AKRO )

Doximity, Inc. Price History

08.07.2025 - DOCS Stock was up 12.4%

  • Doximity's stock experienced a strong bullish movement following its Q1 earnings report, where it surpassed revenue and earnings expectations. This positive performance likely boosted investor confidence in the company's growth prospects.
  • Despite a decrease in gross margin, the overall revenue growth and raised full-year forecast contributed to the stock's upward momentum.
  • The acquisition of Pathway Medical for $63 million to enhance doctors' access to AI-powered clinical reference tools could have also fueled optimism among investors about Doximity's future expansion and innovation in the healthcare sector.
  • The unusual options activity showing a majority of traders taking bullish positions further indicates a positive sentiment surrounding Doximity's stock, potentially driving its upward trajectory.

08.07.2025 - DOCS Stock was up 13.3%

  • Earnings for the first quarter exceeded analyst expectations significantly, leading to a positive impact on the company's stock performance.
  • The acquisition of Pathway Medical for $63 million aims to improve doctors' access to AI-powered clinical reference tools, demonstrating Doximity's focus on expanding its services and embracing technological advancements in healthcare.
  • Strong interest in bullish options trading indicates a positive outlook on Doximity, reflecting confidence in the company's future.
  • The combination of strong earnings, strategic acquisitions, and positive market sentiment likely drove DOCS to experience significant bullish movement.

08.07.2025 - DOCS Stock was up 9.8%

  • This quarter, Doximity (DOCS) surpassed earnings and revenue forecasts, demonstrating a strong financial performance.
  • The recent acquisition of Pathway Medical for $63 million highlights a strategic move into AI-powered tools for healthcare professionals, potentially enhancing the company's technological offerings and market reach.
  • Noteworthy options trading patterns, with a prevalence of bullish positions, suggest an increasing investor faith in Doximity's future prospects, which likely played a role in the uptick in the stock price.

10.09.2025 - DOCS Stock was down 5.7%

  • The bearish movement in DOCS could be attributed to a broader negative sentiment in the healthcare sector, as evidenced by the downgrades in other healthcare companies like Allogene Therapeutics and Akero Therapeutics.
  • The change in analyst outlook for DOCS may have raised concerns among investors, leading to selling pressure on the stock.
  • It is possible that investors are reevaluating their positions in healthcare technology companies, leading to a shift away from previously bullish stocks like DOCS.

02.06.2025 - DOCS Stock was down 1.5%

  • There is a positive upward trend in Doximity's stock price, suggesting potential investor interest or confidence in the company.
  • Conversely, the significant downward movement in DOCS today may be linked to investors seizing profits following a recent uptick in the stock price.
  • It is plausible that investors may have responded to broader market conditions or specific developments in the healthcare sector, causing downward pressure on DOCS.
  • Despite the recent favorable movement in Doximity's stock price, today's bearish turn may be a brief adjustment influenced by various market conditions.

30.08.2025 - DOCS Stock was down 5.2%

  • Concerns about Doximity's competitive position in the digital health sector arose due to comparisons with Hims & Hers, potentially impacting investor sentiment negatively.
  • Representative Jonathan Jackson's substantial purchase of Doximity stock raised questions among investors, possibly leading to a sell-off amid concerns of insider trading or lack of confidence in the company.
  • Activity in the options market hinted at a possible shift in sentiment towards Doximity stock, contributing to the bearish trend as traders likely sought to hedge against further downside risk.

05.05.2025 - DOCS Stock was up 5.1%

  • Despite a recent 4.4% decline in the stock price, Doximity posted strong Q4 results, margin gains, and raised guidance, indicating a positive outlook for the company.
  • The surge in revenue growth and record user engagement can be attributed to the increasing demand for telehealth services, which have become essential in the current healthcare landscape.
  • While other tech stocks like CrowdStrike Holdings, Inc. experienced a decline in pre-market trading after reporting their first-quarter results, Doximity's focus on telehealth solutions seems to be driving its sales and market performance upwards.

05.05.2025 - DOCS Stock was up 5.1%

  • Doximity's strong Q4 revenue growth and record user engagement indicate a growing demand for telehealth and AI tools, driving investor confidence in the stock.
  • The bullish movement in DOCS could be attributed to the increasing reliance on telehealth services, especially during the current global health crisis, leading to higher adoption rates and revenue for the company.
  • While other tech stocks like CrowdStrike are facing downward pressure due to mixed earnings reports, Doximity's focus on the booming telehealth sector seems to be resonating well with investors, propelling the stock higher.

18.06.2025 - DOCS Stock was down 4.6%

  • Despite Doximity (DOCS) closing higher than the previous day, the stock experienced a bearish movement overall.
  • The increase in options trading activity around DOCS stock might indicate uncertainty or speculation among investors.
  • This mixed market behavior could suggest that while there is interest in the company, there may be underlying concerns or factors impacting the stock price negatively.
  • The bullish close followed by a bearish movement could be attributed to profit-taking by investors after the recent price increase, leading to a downward trend in the market.

03.09.2025 - DOCS Stock was up 5.3%

  • DOCS stock demonstrated a robust bullish trend, surpassing the market performance.
  • Speculations surrounding Doximity's growth prospects and platform expansion, particularly in contrast to Hims & Hers, attracted investors' attention.
  • The optimistic market outlook towards companies in the healthcare technology industry, including Doximity, likely influenced the strong bullish movement in DOCS stock.

17.05.2025 - DOCS Stock was up 2.5%

  • Embedding AI tools and clinical workflows into its platform has successfully increased client retention for Doximity.
  • This innovative strategy has likely elevated the platform's value proposition for medical professionals, leading to higher user engagement and the acquisition of new clients.
  • Today's positive movement in DOCS stock may be a response to investors acknowledging the company's initiatives to enhance its services and solidify its market position.

16.04.2025 - DOCS Stock was down 11.4%

  • Despite bullish sentiment from deep-pocketed investors, there was no positive market movement for Doximity (DOCS) on this day.
  • Despite posting better-than-expected earnings for the fourth quarter, the stock saw a significant bearish movement, potentially driven by below-par guidance for the first quarter and full-year 2026.
  • Investor concerns were possibly raised by an investigation, which may have contributed to the stock's bearish trend.
  • Mixed reactions to Doximity's earnings and revenue surprises likely fueled volatility and downward pressure on the stock price.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.